Molecular and cellular mechanism of lung injuries due to exposure to sulfur mustard: a review

References

• Aghanouri R, Ghanei M, Aslani J, Keivani-Amine H, Rastegar F, Karkhane A. 2004. Fibrogenic cytokine levels in bronchoalveolar lavage aspirates 15 years after exposure to sulfur mustard. Am J Physiol Lung Cell Mol Physiol 287:L1160–L1164.
   PubMed Web of Science ®Google Scholar
• Anderson DR, Byers SL, Vesely KR. 2000. Treatment of sulfur mustard (HD)-induced lung injury. J Appl Toxicol 20 Suppl 1:S129–S132.
   Google Scholar
• Anderson HA, Englert R, Gursel I, Shacter E. 2002. Oxidative stress inhibits the phagocytosis of apoptotic cells that have externalized phosphatidylserine. Cell Death Differ 9:616–625.
   PubMedGoogle Scholar
• Attaran D, Lari SM, Khajehdaluee M, Ayatollahi H, Towhidi M, Asnaashari A, Marallu HG, Mazloomi M, Mood MB. 2009. Highly sensitive C-reactive protein levels in Iranian patients with pulmonary complication of sulfur mustard poisoning and its correlation with severity of airway diseases. Hum Exp Toxicol 28:739–745.
   PubMed Web of Science ®Google Scholar
• Beheshti J, Mark EJ, Akbaei HM, Aslani J, Ghanei M. 2006. Mustard lung secrets: long term clinicopathological study following mustard gas exposure. Pathol Res Pract 202:739–744.
   PubMed Web of Science ®Google Scholar
• Behr J, Maier K, Degenkolb B, Krombach F, Vogelmeier C. 1997. Antioxidative and clinical effects of high-dose N-acetylcysteine in fibrosing alveolitis. Adjunctive therapy to maintenance immunosuppression. Am J Respir Crit Care Med 156:1897–1901.
   PubMed Web of Science ®Google Scholar
• Bergmann M, Tiroke A, Schäfer H, Barth J, Haverich A. 1998. Gene expression of profibrotic mediators in bronchiolitis obliterans syndrome after lung transplantation. Scand Cardiovasc J 32:97–103.
   PubMed Web of Science ®Google Scholar
• Bhisey RA, Bagwe AN, Mahimkar MB, Buch SC. 1999. Biological monitoring of bidi industry workers occupationally exposed to tobacco. Toxicol Lett 108:259–265.
   PubMedGoogle Scholar
• Biernacki WA, Kharitonov SA, Barnes PJ. 2003. Increased leukotriene B4 and 8-isoprostane in exhaled breath condensate of patients with exacerbations of COPD. Thorax 58:294–298.
   PubMed Web of Science ®Google Scholar
• Budihardjo I, Oliver H, Lutter M, Luo X, Wang X. 1999. Biochemical pathways of caspase activation during apoptosis. Annu Rev Cell Dev Biol 15:269–290.
   PubMed Web of Science ®Google Scholar
• Car BD, Meloni F, Luisetti M, Semenzato G, Gialdroni-Grassi G, Walz A. 1994. Elevated IL-8 and MCP-1 in the bronchoalveolar lavage fluid of patients with idiopathic pulmonary fibrosis and pulmonary sarcoidosis. Am J Respir Crit Care Med 149:655–659.
   PubMed Web of Science ®Google Scholar
• Coffey M, Hassan J, Feighery C, Fitzgerald M, Bresnihan B. 1989. Rheumatoid factors in cystic fibrosis: associations with disease manifestations and recurrent bacterial infections. Clin Exp Immunol 77:52–57.
   PubMedGoogle Scholar
• Danilko KV, Korytina GF, Akhmidishina LZ, Ianbaeva DG, Zagidullin ShZ, Victorova TV. 2007. [Association of cytokines genes (ILL, IL1RN, TNF, LTA, IL6, IL8, IL0) polymorphic markers with chronic obstructive pulmonary disease]. Mol Biol (Mosk) 41:26–36.
   PubMed Web of Science ®Google Scholar
• Decramer M, Rutten-van Mölken M, Dekhuijzen PN, Troosters T, van Herwaarden C, Pellegrino R, van Schayck CP, Olivieri D, Del Donno M, De Backer W, Lankhorst I, Ardia A. 2005. Effects of N-acetylcysteine on outcomes in chronic obstructive pulmonary disease (Bronchitis Randomized on NAC Cost-Utility Study, BRONCUS): a randomised placebo-controlled trial. Lancet 365:1552–1560.
   PubMed Web of Science ®Google Scholar
• Dekhuijzen PN. 2004. Antioxidant properties of N-acetylcysteine: their relevance in relation to chronic obstructive pulmonary disease. Eur Respir J 23:629–636.
   PubMed Web of Science ®Google Scholar
• Dekhuijzen PN. 2006. [Acetylcysteine in the treatment of severe COPD]. Ned Tijdschr Geneeskd 150:1222–1226.
   PubMedGoogle Scholar
• Dekhuijzen PN, Aben KK, Dekker I, Aarts LP, Wielders PL, van Herwaarden CL, Bast A. 1996. Increased exhalation of hydrogen peroxide in patients with stable and unstable chronic obstructive pulmonary disease. Am J Respir Crit Care Med 154:813–816.
   PubMed Web of Science ®Google Scholar
• Demedts M, Behr J, Buhl R, Costabel U, Dekhuijzen R, Jansen HM, MacNee W, Thomeer M, Wallaert B, Laurent F, Nicholson AG, Verbeken EK, Verschakelen J, Flower CD, Capron F, Petruzzelli S, De Vuyst P, van den Bosch JM, Rodriguez-Becerra E, Corvasce G, Lankhorst I, Sardina M, Montanari M; IFIGENIA Study Group. 2005a. High-dose acetylcysteine in idiopathic pulmonary fibrosis. N Engl J Med 353:2229–2242.
   PubMed Web of Science ®Google Scholar
• Demedts IK, Brusselle GG, Bracke KR, Vermaelen KY, Pauwels RA. 2005b. Matrix metalloproteinases in asthma and COPD. Curr Opin Pharmacol 5:257–263.
   PubMed Web of Science ®Google Scholar
• Demedts IK, Demoor T, Bracke KR, Joos GF, Brusselle GG. 2006. Role of apoptosis in the pathogenesis of COPD and pulmonary emphysema. Respir Res 7:53.
   PubMed Web of Science ®Google Scholar
• Deveraux QL, Roy N, Stennicke HR, Van Arsdale T, Zhou Q, Srinivasula SM, Alnemri ES, Salvesen GS, Reed JC. 1998. IAPs block apoptotic events induced by caspase-8 and cytochrome c by direct inhibition of distinct caspases. EMBO J 17:2215–2223.
   PubMed Web of Science ®Google Scholar
• Dillman JF 3rd, Phillips CS, Dorsch LM, Croxton MD, Hege AI, Sylvester AJ, Moran TS, Sciuto AM. 2005. Genomic analysis of rodent pulmonary tissue following bis-(2-chloroethyl) sulfide exposure. Chem Res Toxicol 18:28–34.
   PubMed Web of Science ®Google Scholar
• El-Gamel A, Sim E, Hasleton P, Hutchinson J, Yonan N, Egan J, Campbell C, Rahman A, Sheldon S, Deiraniya A, Hutchinson IV. 1999. Transforming growth factor beta (TGF-beta) and obliterative bronchiolitis following pulmonary transplantation. J Heart Lung Transplant 18:828–837.
   PubMed Web of Science ®Google Scholar
• Emad A, Emad V. 2007a. Elevated levels of MCP-1, MIP-alpha and MIP-1 beta in the bronchoalveolar lavage (BAL) fluid of patients with mustard gas-induced pulmonary fibrosis. Toxicology 240:60–69.
   PubMed Web of Science ®Google Scholar
• Emad A, Emad Y. 2007b. CD4/CD8 ratio and cytokine levels of the BAL fluid in patients with bronchiectasis caused by sulfur mustard gas inhalation. J Inflamm (Lond) 4:2.
   PubMedGoogle Scholar
• Emad A, Emad Y. 2007c. Increased in CD8 T lymphocytes in the BAL fluid of patients with sulfur mustard gas-induced pulmonary fibrosis. Respir Med 101:786–792.
   PubMed Web of Science ®Google Scholar
• Emad A, Emad Y. 2007d. Levels of cytokine in bronchoalveolar lavage (BAL) fluid in patients with pulmonary fibrosis due to sulfur mustard gas inhalation. J Interferon Cytokine Res 27:38–43.
   PubMed Web of Science ®Google Scholar
• Emad A, Rezaian GR. 1999. Immunoglobulins and cellular constituents of the BAL fluid of patients with sulfur mustard gas-induced pulmonary fibrosis. Chest 115:1346–1351.
   PubMed Web of Science ®Google Scholar
• Emberley ED, Murphy LC, Watson PH. 2004. S100 proteins and their influence on pro-survival pathways in cancer. Biochem Cell Biol 82:508–515.
   PubMed Web of Science ®Google Scholar
• Fadok V, Bratton D, Konowal A, Freed P, Westcott J, Henson P. 1998. Macrophages that have digested apoptotic cells in vitro inhibit proinflammatory cytokine production through autocrine/paracrine mechanisms involving TGF-b, PGE2 and PAF. J Clin Invest 90:1513–1522.
   Google Scholar
• Fadok VA, Voelker DR, Campbell PA, Cohen JJ, Bratton DL, Henson PM. 1992. Exposure of phosphatidylserine on the surface of apoptotic lymphocytes triggers specific recognition and removal by macrophages. J Immunol 148:2207–2216.
   PubMed Web of Science ®Google Scholar
• Fidan F, Unlü M, Köken T, Tetik L, Akgün S, Demirel R, Serteser M. 2005. Oxidant-antioxidant status and pulmonary function in welding workers. J Occup Health 47:286–292.
   PubMed Web of Science ®Google Scholar
• Freire-de-Lima CG, Xiao YQ, Gardai SJ, Bratton DL, Schiemann WP, Henson PM. 2006. Apoptotic cells, through transforming growth factor-beta, coordinately induce anti-inflammatory and suppress pro-inflammatory eicosanoid and NO synthesis in murine macrophages. J Biol Chem 281:38376–38384.
   PubMed Web of Science ®Google Scholar
• Gabay C, Kushner I. 1999. Acute-phase proteins and other systemic responses to inflammation. N Engl J Med 340:448–454.
   PubMed Web of Science ®Google Scholar
• Ghanei M, Ghayumi M, Ahakzani N, Rezvani O, Jafari M, Ani A, Aslani J. 2010. Noninvasive diagnosis of bronchiolitis obliterans due to sulfur mustard exposure: could high-resolution computed tomography give us a clue? Radiol Med 115:413–420.
   PubMed Web of Science ®Google Scholar
• Ghanei M, Harandi AA. 2007. Long term consequences from exposure to sulfur mustard: a review. Inhal Toxicol 19:451–456.
   PubMed Web of Science ®Google Scholar
• Ghanei M, Khalili AR, Arab MJ, Mojtahedzadeh M, Aslani J, Lessan-Pezeshki M, Panahi Y, Alaeddini F. 2005. Diagnostic and therapeutic value of short-term corticosteroid therapy in exacerbation of mustard gas-induced chronic bronchitis. Basic Clin Pharmacol Toxicol 97:302–305.
   PubMed Web of Science ®Google Scholar
• Ghanei M, Mokhtari M, Mohammad MM, Aslani J. 2004. Bronchiolitis obliterans following exposure to sulfur mustard: chest high resolution computed tomography. Eur J Radiol 52:164–169.
   PubMed Web of Science ®Google Scholar
• Ghanei M, Tazelaar HD, Chilosi M, Harandi AA, Peyman M, Akbari HM, Shamsaei H, Bahadori M, Aslani J, Mohammadi A. 2008. An international collaborative pathologic study of surgical lung biopsies from mustard gas-exposed patients. Respir Med 102:825–830.
   PubMed Web of Science ®Google Scholar
• Grandjean EM, Berthet P, Ruffmann R, Leuenberger P. 2000. Efficacy of oral long-term N-acetylcysteine in chronic bronchopulmonary disease: a meta-analysis of published double-blind, placebo-controlled clinical trials. Clin Ther 22:209–221.
   PubMed Web of Science ®Google Scholar
• Han S, Espinoza LA, Liao H, Boulares AH, Smulson ME. 2004. Protection by antioxidants against toxicity and apoptosis induced by the sulphur mustard analog 2-chloroethylethyl sulphide (CEES) in Jurkat T cells and normal human lymphocytes. Br J Pharmacol 141:795–802.
   PubMed Web of Science ®Google Scholar
• Haslett C. 1999. Granulocyte apoptosis and its role in the resolution and control of lung inflammation. Am J Respir Crit Care Med 160:S5–11.
   PubMed Web of Science ®Google Scholar
• Heinrich A, Balszuweit F, Thiermann H, Kehe K. 2009. Rapid simultaneous determination of apoptosis, necrosis, and viability in sulfur mustard exposed HaCaT cell cultures. Toxicol Lett 191:260–267.
   PubMed Web of Science ®Google Scholar
• Henricks PA, Nijkamp FP. 2001. Reactive oxygen species as mediators in asthma. Pulm Pharmacol Ther 14:409–420.
   PubMed Web of Science ®Google Scholar
• Henson PM, Vandivier RW, Douglas IS. 2006. Cell death, remodeling, and repair in chronic obstructive pulmonary disease? Proc Am Thorac Soc 3:713–717.
   PubMedGoogle Scholar
• Higashimoto Y, Iwata T, Okada M, Satoh H, Fukuda K, Tohda Y. 2009. Serum biomarkers as predictors of lung function decline in chronic obstructive pulmonary disease. Respir Med 103:1231–1238.
   PubMed Web of Science ®Google Scholar
• Hodge S, Hodge G, Scicchitano R, Reynolds PN, Holmes M. 2003. Alveolar macrophages from subjects with chronic obstructive pulmonary disease are deficient in their ability to phagocytose apoptotic airway epithelial cells. Immunol Cell Biol 81:289–296.
   PubMed Web of Science ®Google Scholar
• Hutchison KA, Matic G, Meshinchi S, Bresnick EH, Pratt WB. 1991. Redox manipulation of DNA binding activity and BuGR epitope reactivity of the glucocorticoid receptor. J Biol Chem 266:10505–10509.
   PubMedGoogle Scholar
• Janssen LJ. 2001. Isoprostanes: an overview and putative roles in pulmonary pathophysiology. Am J Physiol Lung Cell Mol Physiol 280:L1067–L1082.
   PubMed Web of Science ®Google Scholar
• Jörres RA, Holz O, Zachgo W, Timm P, Koschyk S, Müller B, Grimminger F, Seeger W, Kelly FJ, Dunster C, Frischer T, Lubec G, Waschewski M, Niendorf A, Magnussen H. 2000. The effect of repeated ozone exposures on inflammatory markers in bronchoalveolar lavage fluid and mucosal biopsies. Am J Respir Crit Care Med 161:1855–1861.
   PubMed Web of Science ®Google Scholar
• Kawikova I, Barnes PJ, Takahashi T, Tadjkarimi S, Yacoub MH, Belvisi MG. 1996. 8-Epi-PGF2 alpha, a novel noncyclooxygenase-derived prostaglandin, constricts airways in vitro. Am J Respir Crit Care Med 153:590–596.
   PubMed Web of Science ®Google Scholar
• Kehe K, Balszuweit F, Steinritz D, Thiermann H. 2009. Molecular toxicology of sulfur mustard-induced cutaneous inflammation and blistering. Toxicology 263:12–19.
   PubMed Web of Science ®Google Scholar
• Kehe K, Raithel K, Kreppel H, Jochum M, Worek F, Thiermann H. 2008. Inhibition of poly(ADP-ribose) polymerase (PARP) influences the mode of sulfur mustard (SM)-induced cell death in HaCaT cells. Arch Toxicol 82:461–470.
   PubMed Web of Science ®Google Scholar
• Kehe K, Reisinger H, Szinicz L. 2000. Sulfur mustard induces apoptosis and necrosis in SCL II cells in vitro. J Appl Toxicol 20 Suppl 1:S81–S86.
   PubMedGoogle Scholar
• Khateri S, Ghanei M, Keshavarz S, Soroush M, Haines D. 2003. Incidence of lung, eye, and skin lesions as late complications in 34,000 Iranians with wartime exposure to mustard agent. J Occup Environ Med 45:1136–1143.
   PubMed Web of Science ®Google Scholar
• Kim Y, Suh N, Sporn M, Reed JC. 2002. An inducible pathway for degradation of FLIP protein sensitizes tumor cells to TRAIL-induced apoptosis. J Biol Chem 277:22320–22329.
   PubMed Web of Science ®Google Scholar
• Krueger A, Schmitz I, Baumann S, Krammer PH, Kirchhoff S. 2001. Cellular FLICE-inhibitory protein splice variants inhibit different steps of caspase-8 activation at the CD95 death-inducing signaling complex. J Biol Chem 276:20633–20640.
   PubMed Web of Science ®Google Scholar
• Kumar S. 1999. Regulation of caspase activation in apoptosis: implications in pathogenesis and treatment of disease. Clin Exp Pharmacol Physiol 26:295–303.
   PubMed Web of Science ®Google Scholar
• Lee TM, Lin MS, Chang NC. 2008. Usefulness of C-reactive protein and interleukin-6 as predictors of outcomes in patients with chronic obstructive pulmonary disease receiving pravastatin. Am J Cardiol 101:530–535.
   PubMed Web of Science ®Google Scholar
• MacNee W. 2001. Oxidative stress and lung inflammation in airways disease. Eur J Pharmacol 429:195–207.
   PubMed Web of Science ®Google Scholar
• MacNee W. 2006. Oxidative stress and chronic obstructive pulmonary disease. Eur Respir Monogr 11:100–129.
   Google Scholar
• MacNee W, Tuder RM. 2009. New paradigms in the pathogenesis of chronic obstructive pulmonary disease I. Proc Am Thorac Soc 6:527–531.
   PubMedGoogle Scholar
• McDonald PP, Fadok VA, Bratton D, Henson PM. 1999. Transcriptional and translational regulation of inflammatory mediator production by endogenous TGF-beta in macrophages that have ingested apoptotic cells. J Immunol 163:6164–6172.
   PubMed Web of Science ®Google Scholar
• McPhillips K, Janssen WJ, Ghosh M, Byrne A, Gardai S, Remigio L, Bratton DL, Kang JL, Henson P. 2007. TNF-alpha inhibits macrophage clearance of apoptotic cells via cytosolic phospholipase A2 and oxidant-dependent mechanisms. J Immunol 178:8117–8126.
   PubMed Web of Science ®Google Scholar
• Mehrani H, Ghanei M, Aslani J, Golmanesh L. 2009. Bronchoalveolar lavage fluid proteomic patterns of sulfur mustard-exposed patients. Proteomics Clin Appl 3:1191–1200.
   PubMed Web of Science ®Google Scholar
• Mol MA, van den Berg RM, Benschop HP. 2009. Involvement of caspases and transmembrane metalloproteases in sulphur mustard-induced microvesication in adult human skin in organ culture: directions for therapy. Toxicology 258:39–46.
   PubMed Web of Science ®Google Scholar
• Moon C, Lee YJ, Park HJ, Chong YH, Kang JL. 2010. N-acetylcysteine inhibits RhoA and promotes apoptotic cell clearance during intense lung inflammation. Am J Respir Crit Care Med 181:374–387.
   PubMedGoogle Scholar
• Morrow JD. 2000. The isoprostanes: their quantification as an index of oxidant stress status in vivo. Drug Metab Rev 32:377–385.
   PubMed Web of Science ®Google Scholar
• Naghii MR. 2002. Sulfur mustard intoxication, oxidative stress, and antioxidants. Mil Med 167:573–575.
   PubMed Web of Science ®Google Scholar
• Navab M, Ananthramaiah GM, Reddy ST, Van Lenten BJ, Ansell BJ, Fonarow GC, Vahabzadeh K, Hama S, Hough G, Kamranpour N, Berliner JA, Lusis AJ, Fogelman AM. 2004. The oxidation hypothesis of atherogenesis: the role of oxidized phospholipids and HDL. J Lipid Res 45:993–1007.
   PubMed Web of Science ®Google Scholar
• Nocker RE, Schoonbrood DF, van de Graaf EA, Hack CE, Lutter R, Jansen HM, Out TA. 1996. Interleukin-8 in airway inflammation in patients with asthma and chronic obstructive pulmonary disease. Int Arch Allergy Immunol 109:183–191.
   PubMed Web of Science ®Google Scholar
• Nowak D, Kasielski M, Antczak A, Pietras T, Bialasiewicz P. 1999. Increased content of thiobarbituric acid-reactive substances and hydrogen peroxide in the expired breath condensate of patients with stable chronic obstructive pulmonary disease: no significant effect of cigarette smoking. Respir Med 93:389–396.
   PubMed Web of Science ®Google Scholar
• Okamoto K, Tanaka H, Ogawa H, Makino Y, Eguchi H, Hayashi S, Yoshikawa N, Poellinger L, Umesono K, Makino I. 1999. Redox-dependent regulation of nuclear import of the glucocorticoid receptor. J Biol Chem 274:10363–10371.
   PubMedGoogle Scholar
• Okazawa A, Kawikova I, Cui ZH, Skoogh BE, Lötvall J. 1997. 8-Epi-PGF2alpha induces airflow obstruction and airway plasma exudation in vivo. Am J Respir Crit Care Med 155:436–441.
   PubMed Web of Science ®Google Scholar
• Pela R, Calcagni AM, Subiaco S, Isidori P, Tubaldi A, Sanguinetti CM. 1999. N-acetylcysteine reduces the exacerbation rate in patients with moderate to severe COPD. Respiration 66:495–500.
   PubMed Web of Science ®Google Scholar
• Pirzad G, Jafari M, Tavana S, Sadrayee H, Ghavami S, Shajiei A, Ghanei M. 2010. The Role of Fas-FasL Signaling Pathway in Induction of Apoptosis in Patients with Sulfur Mustard-Induced Chronic Bronchiolitis. J Toxicol 2010:373612.
   PubMedGoogle Scholar
• Porter AG, Jänicke RU. 1999. Emerging roles of caspase-3 in apoptosis. Cell Death Differ 6:99–104.
   PubMed Web of Science ®Google Scholar
• Pourfarzam S, Ghazanfari T, Yaraee R, Ghasemi H, Hassan ZM, Faghihzadeh S, Ardestani SK, Kariminia A, Fallahi F, Soroush MR, Merasizadeh J, Mahlojirad M, Naghizadeh MM, Ghanei M. 2009. Serum levels of IL-8 and IL-6 in the long term pulmonary complications induced by sulfur mustard: Sardasht-Iran Cohort Study. Int Immunopharmacol 9:1482–1488.
   PubMed Web of Science ®Google Scholar
• Rahman I, van Schadewijk AA, Crowther AJ, Hiemstra PS, Stolk J, MacNee W, De Boer WI. 2002. 4-Hydroxy-2-nonenal, a specific lipid peroxidation product, is elevated in lungs of patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 166:490–495.
   PubMed Web of Science ®Google Scholar
• Ray R, Keyser B, Benton B, Daher A, Simbulan-Rosenthal CM, Rosenthal DS. 2008. Sulfur mustard induces apoptosis in cultured normal human airway epithelial cells: evidence of a dominant caspase-8-mediated pathway and differential cellular responses. Drug Chem Toxicol 31:137–148.
   PubMed Web of Science ®Google Scholar
• Ray R, Simbulan-Rosenthal CM, Keyser BM, Benton B, Anderson D, Holmes W, Trabosh VA, Daher A, Rosenthal DS. 2010. Sulfur mustard induces apoptosis in lung epithelial cells via a caspase amplification loop. Toxicology 271:94–99.
   PubMed Web of Science ®Google Scholar
• Repine JE, Bast A, Lankhorst I. 1997. Oxidative stress in chronic obstructive pulmonary disease. Oxidative Stress Study Group. Am J Respir Crit Care Med 156:341–357.
   PubMed Web of Science ®Google Scholar
• Retamales I, Elliott WM, Meshi B, Coxson HO, Pare PD, Sciurba FC, Rogers RM, Hayashi S, Hogg JC. 2001. Amplification of inflammation in emphysema and its association with latent adenoviral infection. Am J Respir Crit Care Med 164:469–473.
   PubMed Web of Science ®Google Scholar
• Riise GC, Larsson S, Larsson P, Jeansson S, Andersson BA. 1994. The intrabronchial microbial flora in chronic bronchitis patients: a target for N-acetylcysteine therapy? Eur Respir J 7:94–101.
   PubMed Web of Science ®Google Scholar
• Rosenthal DS, Simbulan-Rosenthal CM, Iyer S, Spoonde A, Smith W, Ray R, Smulson ME. 1998. Sulfur mustard induces markers of terminal differentiation and apoptosis in keratinocytes via a Ca2+-calmodulin and caspase-dependent pathway. J Invest Dermatol 111:64–71.
   PubMed Web of Science ®Google Scholar
• Rosenthal DS, Velena A, Chou FP, Schlegel R, Ray R, Benton B, Anderson D, Smith WJ, Simbulan-Rosenthal CM. 2003. Expression of dominant-negative Fas-associated death domain blocks human keratinocyte apoptosis and vesication induced by sulfur mustard. J Biol Chem 278:8531–8540.
   PubMed Web of Science ®Google Scholar
• Sakaida H. 1995. [IgG rheumatoid factor in rheumatoid arthritis with interstitial lung disease]. Ryumachi 35:671–677.
   PubMedGoogle Scholar
• Salvi SS, Barnes PJ. 2009. Chronic obstructive pulmonary disease in non-smokers. Lancet 374:733–743.
   PubMed Web of Science ®Google Scholar
• Shapiro SD. 2002. Proteinases in chronic obstructive pulmonary disease. Biochem Soc Trans 30:98–102.
   PubMed Web of Science ®Google Scholar
• Shapiro SD. 2003. Proteolysis in the lung. Eur Respir J Suppl 44:30s–32s.
   PubMedGoogle Scholar
• Shohrati M, Aslani J, Eshraghi M, Alaedini F, Ghanei M. 2008. Therapeutics effect of N-acetyl cysteine on mustard gas exposed patients: evaluating clinical aspect in patients with impaired pulmonary function test. Respir Med 102:443–448.
   PubMed Web of Science ®Google Scholar
• Shohrati M, Ghanei M, Shamspour N, Babaei F, Abadi MN, Jafari M, Harandi AA, Ali AH. 2010. Glutathione and malondialdehyde levels in late pulmonary complications of sulfur mustard intoxication. Lung 188:77–83.
   PubMed Web of Science ®Google Scholar
• Sourdeval M, Lemaire C, Deniaud A, Taysse L, Daulon S, Breton P, Brenner C, Boisvieux-Ulrich E, Marano F. 2006. Inhibition of caspase-dependent mitochondrial permeability transition protects airway epithelial cells against mustard-induced apoptosis. Apoptosis 11:1545–1559.
   PubMed Web of Science ®Google Scholar
• Steinritz D, Emmler J, Hintz M, Worek F, Kreppel H, Szinicz L, Kehe K. 2007. Apoptosis in sulfur mustard treated A549 cell cultures. Life Sci 80:2199–2201.
   PubMed Web of Science ®Google Scholar
• Stey C, Steurer J, Bachmann S, Medici TC, Tramèr MR. 2000. The effect of oral N-acetylcysteine in chronic bronchitis: a quantitative systematic review. Eur Respir J 16:253–262.
   PubMed Web of Science ®Google Scholar
• Takabatake N, Nakamura H, Inoue S, Terashita K, Yuki H, Kato S, Yasumura S, Tomoike H. 2000. Circulating levels of soluble Fas ligand and soluble Fas in patients with chronic obstructive pulmonary disease. Respir Med 94:1215–1220.
   PubMed Web of Science ®Google Scholar
• Tanino M, Betsuyaku T, Takeyabu K, Tanino Y, Yamaguchi E, Miyamoto K, Nishimura M. 2002. Increased levels of interleukin-8 in BAL fluid from smokers susceptible to pulmonary emphysema. Thorax 57:405–411.
   PubMed Web of Science ®Google Scholar
• Thorburn A. 2004. Death receptor-induced cell killing. Cell Signal 16:139–144.
   PubMed Web of Science ®Google Scholar
• Thorleifsson SJ, Margretardottir OB, Gudmundsson G, Olafsson I, Benediktsdottir B, Janson C, Buist AS, Gislason T. 2009. Chronic airflow obstruction and markers of systemic inflammation: results from the BOLD study in Iceland. Respir Med 103:1548–1553.
   PubMedGoogle Scholar
• Traves SL, Culpitt SV, Russell RE, Barnes PJ, Donnelly LE. 2002. Increased levels of the chemokines GROalpha and MCP-1 in sputum samples from patients with COPD. Thorax 57:590–595.
   PubMed Web of Science ®Google Scholar
• Tuder RM, Zhen L, Cho CY, Taraseviciene-Stewart L, Kasahara Y, Salvemini D, Voelkel NF, Flores SC. 2003. Oxidative stress and apoptosis interact and cause emphysema due to vascular endothelial growth factor receptor blockade. Am J Respir Cell Mol Biol 29:88–97.
   PubMed Web of Science ®Google Scholar
• Ucar M, Korkmaz A, Reiter RJ, Yaren H, Oter S, Kurt B, Topal T. 2007. Melatonin alleviates lung damage induced by the chemical warfare agent nitrogen mustard. Toxicol Lett 173:124–131.
   PubMed Web of Science ®Google Scholar
• Vahrmeijer AL, van Dierendonck JH, Schutrups J, van de Velde CJ, Mulder GJ. 1999. Effect of glutathione depletion on inhibition of cell cycle progression and induction of apoptosis by melphalan (L-phenylalanine mustard) in human colorectal cancer cells. Biochem Pharmacol 58:655–664.
   PubMed Web of Science ®Google Scholar
• van Overveld FJ, Demkow U, Górecka D, de Backer WA, Zielinski J. 2005. New developments in the treatment of COPD: comparing the effects of inhaled corticosteroids and N-acetylcysteine. J Physiol Pharmacol 56 Suppl 4:135–142.
   PubMedGoogle Scholar
• Vandivier RW, Fadok VA, Hoffmann PR, Bratton DL, Penvari C, Brown KK, Brain JD, Accurso FJ, Henson PM. 2002. Elastase-mediated phosphatidylserine receptor cleavage impairs apoptotic cell clearance in cystic fibrosis and bronchiectasis. J Clin Invest 109:661–670.
   PubMed Web of Science ®Google Scholar
• Vandivier RW, Henson PM, Douglas IS. 2006. Burying the dead: the impact of failed apoptotic cell removal (efferocytosis) on chronic inflammatory lung disease. Chest 129:1673–1682.
   PubMed Web of Science ®Google Scholar
• Yasuda N, Gotoh K, Minatoguchi S, Asano K, Nishigaki K, Nomura M, Ohno A, Watanabe M, Sano H, Kumada H, Sawa T, Fujiwara H. 1998. An increase of soluble Fas, an inhibitor of apoptosis, associated with progression of COPD. Respir Med 92:993–999.
   PubMed Web of Science ®Google Scholar
• Yui S, Nakatani Y, Mikami M. 2003. Calprotectin (S100A8/S100A9), an inflammatory protein complex from neutrophils with a broad apoptosis-inducing activity. Biol Pharm Bull 26:753–760.
   PubMed Web of Science ®Google Scholar